Page last updated: 2024-09-03

1-((3-hydroxy-4-methoxy)-1-naphthoxy)-2,3-propanediol and hydroxyindoleacetic acid

1-((3-hydroxy-4-methoxy)-1-naphthoxy)-2,3-propanediol has been researched along with hydroxyindoleacetic acid in 2 studies

Compound Research Comparison

Studies
(1-((3-hydroxy-4-methoxy)-1-naphthoxy)-2,3-propanediol)
Trials
(1-((3-hydroxy-4-methoxy)-1-naphthoxy)-2,3-propanediol)
Recent Studies (post-2010)
(1-((3-hydroxy-4-methoxy)-1-naphthoxy)-2,3-propanediol)
Studies
(hydroxyindoleacetic acid)
Trials
(hydroxyindoleacetic acid)
Recent Studies (post-2010) (hydroxyindoleacetic acid)
9418,911322594

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Banken, L; Dingemanse, J; Guentert, TW; Holford, NH1
Anttila, M; Heinonen, E; Helminen, A; Huupponen, R; Laine, K; Mäki-Ikola, O; Reinikainen, K; Scheinin, M1

Trials

2 trial(s) available for 1-((3-hydroxy-4-methoxy)-1-naphthoxy)-2,3-propanediol and hydroxyindoleacetic acid

ArticleYear
Monoamine oxidase-A: pharmacodynamics in humans of moclobemide, a reversible and selective inhibitor.
    British journal of clinical pharmacology, 1994, Volume: 37, Issue:5

    Topics: Administration, Oral; Adult; Benzamides; Biological Availability; Chromatography, High Pressure Liquid; Humans; Hydroxyindoleacetic Acid; Male; Metabolic Clearance Rate; Moclobemide; Models, Biological; Monoamine Oxidase Inhibitors; Naphthols; Propylene Glycols; Random Allocation

1994
Lack of adverse interactions between concomitantly administered selegiline and citalopram.
    Clinical neuropharmacology, 1997, Volume: 20, Issue:5

    Topics: Adult; Antidepressive Agents; Citalopram; Double-Blind Method; Drug Administration Schedule; Drug Interactions; Epinephrine; Humans; Hydroxyindoleacetic Acid; Male; Monoamine Oxidase Inhibitors; Naphthols; Norepinephrine; Placebos; Prolactin; Propylene Glycols; Selective Serotonin Reuptake Inhibitors; Selegiline; Serotonin

1997